(Q38415996)

2 September 2017

Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study (English)

1 reference

attention deficit hyperactivity disorder

2 September 2017

0 references

1 reference

1 reference

1 reference

inferred from title

author

Søren Dinesen Østergaard

object named as

Søren Dinesen Østergaard

2

0 references

Søren Dalsgaard

object named as

Søren Dalsgaard

1

0 references

Preben Bo Mortensen

object named as

Preben Bo Mortensen

4

0 references

author name string

James F Leckman

3

1 reference

PubMed ID

25726514

2 September 2017

Marianne Giørtz Pedersen

5

1 reference

PubMed ID

25726514

2 September 2017

language of work or name

English

0 references

publication date

26 February 2015

1 reference

2 September 2017

7

1 reference

inferred from page(s)

published in

The Lancet

1 reference

2 September 2017

385

1 reference

2 September 2017

9983

1 reference

2 September 2017

2190-2196

1 reference

Excess mortality, causes of death and life expectancy in 270,770 patients with recent onset of mental disorders in Denmark, Finland and Sweden

2 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961684-6

7 January 2021

The Stockholm Manifesto. Creating a safe environment for children in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961684-6

7 January 2021

Childhood psychiatric disorder and unintentional injury: findings from a national cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961684-6

7 January 2021

Serious transport accidents in adults with attention-deficit/hyperactivity disorder and the effect of medication: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961684-6

7 January 2021

ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood - a naturalistic long-term follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961684-6

7 January 2021

Long-term criminal outcome of children with attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961684-6

7 January 2021

Attention Deficit Hyperactivity Disorder (ADHD) among longer-term prison inmates is a prevalent, persistent and disabling disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961684-6

7 January 2021

Association between Attention-Deficit Hyperactivity Disorder in childhood and schizophrenia later in adulthood

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961684-6

7 January 2021

Poster #S74 INCREASED RISK OF SCHIZOPHRENIA SPECTRUM DISORDERS AFTER ALL CHILDHOOD PSYCHIATRIC DISORDERS – NATIONWIDE STUDY

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961684-6

7 January 2021

Conduct problems, gender and adult psychiatric outcome of children with attention-deficit hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961684-6

7 January 2021

Mortality, ADHD, and psychosocial adversity in adults with childhood ADHD: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961684-6

7 January 2021

The Danish Psychiatric Central Research Register.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961684-6

7 January 2021

Gender and injuries predict stimulant medication use.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961684-6

7 January 2021

Why fewer females than males are diagnosed with attention-deficit-hyperactivity disorder: it might not be hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961684-6

7 January 2021

Risk for injury in preschoolers: relationship to attention deficit hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961684-6

7 January 2021

Coffee consumption during pregnancy and the risk of hyperkinetic disorder and ADHD: a prospective cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961684-6

7 January 2021

Five-fold increase in national prevalence rates of attention-deficit/hyperactivity disorder medications for children and adolescents with autism spectrum disorder, attention-deficit/hyperactivity disorder, and other psychiatric disorders: a Danish r

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961684-6

7 January 2021

Relative standards in ADHD diagnoses: The role of specialist behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961684-6

7 January 2021

Common Danish standards in prescribing medication for children and adolescents with ADHD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961684-6

7 January 2021

Cardiovascular events and death in children exposed and unexposed to ADHD agents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961684-6

7 January 2021

Drugs for attention deficit–hyperactivity disorder do not increase the mid-term risk of sudden death in children: A meta-analysis of observational studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961684-6

7 January 2021

Comparative mortality risk in adult patients with schizophrenia, depression, bipolar disorder, anxiety disorders, and attention-deficit/hyperactivity disorder participating in psychopharmacology clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961684-6

7 January 2021

Mortality associated with attention-deficit hyperactivity disorder (ADHD) drug treatment: a retrospective cohort study of children, adolescents and young adults using the general practice research database

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961684-6

7 January 2021

Cardiovascular safety of stimulants in children with attention-deficit/hyperactivity disorder: a nationwide prospective cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961684-6

7 January 2021

Consequences of ADHD medication use for children's outcomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961684-6

7 January 2021

Medication for attention deficit-hyperactivity disorder and criminality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961684-6

7 January 2021

Attention deficit/hyperactivity disorder across the lifespan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961684-6

7 January 2021

10.1016/S0140-6736(14)61684-6

Identifiers

DOI

1 reference

2 September 2017

1 reference

PubMed ID

25726514